“Coronavirus SARS-CoV-2”. 2020년 5월 15일에 원본 문서에서 보존된 문서. 2020-05-15] 웹 아카이브에서에 확인함.지원되지 않는 변수 무시됨: |werk= (도움말); 지원되지 않는 변수 무시됨: |abruf= (도움말); 지원되지 않는 변수 무시됨: |datum= (도움말); 지원되지 않는 변수 무시됨: |hrsg= (도움말); 지원되지 않는 변수 무시됨: |kommentar= (도움말); 다음 날짜 값 확인 필요: |access-date= (도움말)
doi.org
dx.doi.org
C. Tikellis, M. C. Thomas: Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. In: International journal of peptides. Vol. 2012, 2012, S. 256294, doi:10.1155/2012/256294, PMID 22536270.
W. Li, M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, M. Farzan: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. In: Nature. Vol. 426, No. 6965, November 2003, S. 450–454, doi:10.1038/nature02145, PMID 14647384
Yushun Wan, Jian Shang, Rachel Graham, Ralph S. Baric, Fang Li: Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus, doi:10.1128/JVI.00127-20
P. Towler, B. Staker, S. G. Prasad, S. Menon, J. Tang, T. Parsons, D. Ryan, M. Fisher, D. Williams, N. A. Dales, M. A. Patane, M. W. Pantoliano: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. In: Journal of Biological Chemistry. Vol. 279, No. 17, April 2004, S. 17996–18007, doi:10.1074/jbc.M311191200, PMID 14754895.
C. A. McKinney, C. Fattah, C. M. Loughrey, G. Milligan, S. A. Nicklin: Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. In: Clinical science. Vol. 126, No. 12, June 2014, S. 815–827, doi:10.1042/CS20130436, PMID 24593683 (Review).
Y. Inoue, N. Tanaka, Y. Tanaka, S. Inoue, K. Morita, M. Zhuang, T. Hattori, K. Sugamura: Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. In: Journal of Virology. Vol. 81, No. 16, August 2007, S. 8722–8729, doi:10.1128/JVI.00253-07, PMID 17522231.
H. Wang, P. Yang, K. Liu, F. Guo, Y. Zhang, G. Zhang, C. Jiang: SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. In: Cell research. Vol. 18, No. 2, February 2008, S. 290–301, doi:10.1038/cr.2008.15, PMID 18227861.
S. Matsuyama, N. Nagata, K. Shirato, M. Kawase, M. Takeda, F. Taguchi: Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. In: Journal of Virology. Vol. 84, No. 24, December 2010, S. 12658–12664, doi:10.1128/JVI.01542-10, PMID 20926566.
S. K. Wong, W. Li, M. J. Moore, H. Choe, M. Farzan: A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. In: Journal of Biological Chemistry. Vol. 279, No. 5, January 2004, S. 3197–3201, doi:10.1074/jbc.C300520200, PMID 14670965.
L. Du, Y. He, Y. Zhou, S. Liu, B. J. Zheng, S. Jiang: The spike protein of SARS-CoV–a target for vaccine and therapeutic development. In: Nature reviews. Microbiology. Vol. 7, No. 3, March 2009, S. 226–236, doi:10.1038/nrmicro2090, PMID 19198616 (Review).
F. Li, W. Li, M. Farzan, S. C. Harrison: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. In: Science. Vol. 309, No. 5742, September 2005, S. 1864–1868, doi:10.1126/science.1116480, PMID 16166518.
F. Li: Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. In: Journal of Virology. Vol. 82, No. 14, July 2008, S. 6984–6991, doi:10.1128/JVI.00442-08, PMID 18448527.
M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T. S. Schiergens, G. Herrler, N. H. Wu, A. Nitsche, M. A. Müller, C. Drosten, S. Pöhlmann: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. In: Cell. March 2020, doi:10.1016/j.cell.2020.02.052, PMID 32142651.
Ying-Ying Zheng, Yi-Tong Ma, Jin-Ying Zhang, Xiang Xie: Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’. In: Nature Reviews Cardiology. 30. March 2020, doi:10.1038/s41569-020-0369-9.
T. Hirano, M. Murakami: COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. In: Immunity. [elektronische Veröffentlichung vor dem Druck] April 2020, doi:10.1016/j.immuni.2020.04.003, PMID 32325025.
Y. Y. Zheng, Y. T. Ma, J. Y. Zhang, X. Xie: COVID-19 and the cardiovascular system. In: Nature reviews. Cardiology. 5. March 2020, doi:10.1038/s41569-020-0360-5, PMID 32139904.
C. M. Ferrario, J. Jessup, M. C. Chappell, D. B. Averill, K. B. Brosnihan, E. A. Tallant, D. I. Diz, P. E. Gallagher: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. In: Circulation. Vol. 111, No. 20, May 2005, S. 2605–2610, doi:10.1161/CIRCULATIONAHA.104.510461, PMID 15897343.
Y. Li, Z. Zeng, Y. Li, W. Huang, M. Zhou, X. Zhang, W. Jiang: Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. In: Shock. Vol. 43, No. 4, April 2015, S. 395–404, doi:10.1097/SHK.0000000000000302, PMID 25768373.
R. M. Wösten-van Asperen, R. Lutter, P. A. Specht, G. N. Moll, J. B. van Woensel, C. M. van der Loos, H. van Goor, J. Kamilic, S. Florquin, A. P. Bos: Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. In: The Journal of pathology. Vol. 225, No. 4, December 2011, S. 618–627, doi:10.1002/path.2987, PMID 22009550.
S. Keidar, A. Gamliel-Lazarovich, M. Kaplan, E. Pavlotzky, S. Hamoud, T. Hayek, R. Karry, Z. Abassi: Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. In: Circulation research. Vol. 97, No. 9, October 2005, S. 946–953, doi:10.1161/01.RES.0000187500.24964.7A, PMID 16179584.
J. C. Zhong, J. Y. Ye, H. Y. Jin, X. Yu, H. M. Yu, D. L. Zhu, P. J. Gao, D. Y. Huang, M. Shuster, H. Loibner, J. M. Guo, X. Y. Yu, B. X. Xiao, Z. H. Gong, J. M. Penninger, G. Y. Oudit: Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. In: Regulatory peptides. Vol. 166, No. 1–3, January 2011, S. 90–97, doi:10.1016/j.regpep.2010.09.005, PMID 20854846.
S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie, A. J. Turner: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. In: Journal of Biological Chemistry. Vol. 275, No. 43, October 2000, S. 33238–33243, doi:10.1074/jbc.M002615200, PMID 10924499.
Zikuan Leng, Rongjia Zhu, Wei Hou, Yingmei Feng, Yanlei Yang, Qin Han, Guangliang Shan, Fanyan Meng, Dongshu Du, Shihua Wang, Junfen Fan, Wenjing Wang, Luchan Deng, Hongbo Shi, Hongjun Li, Zhongjie Hu, Fengchun Zhang, Jinming Gao, Hongjian Liu, Xiaoxia Li, Yangyang Zhao, Kan Yin, Xijing He, Zhengchao Gao, Yibin Wang, B. o. Yang, Ronghua Jin, Ilia Stambler, Lee Wei Lim, Huanxing Su, Alexey Moskalev, Antonio Cano, Sasanka Chakrabarti, Kyung-Jin Min, Georgina Ellison-Hughes, Calogero Caruso, Kunlin Jin, Robert Chunhua Zhao: Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. In: Aging and disease. Vol. 11, 9. March 2020, S. 216, doi:10.14336/AD.2020.0228.
B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, D. L. Clement, A. Coca, G. de Simone, A. Dominiczak, T. Kahan, F. Mahfoud, J. Redon, L. Ruilope, A. Zanchetti, M. Kerins, S. E. Kjeldsen, R. Kreutz, S. Laurent, G. Y. Lip, R. McManus, K. Narkiewicz, F. Ruschitzka, R. E. Schmieder, E. Shlyakhto, C. Tsioufis, V. Aboyans, I. Desormais: 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. In: Journal of hypertension. Vol. 36, No. 10, 10 2018, S. 1953–2041, doi:10.1097/HJH.0000000000001940, PMID 30234752.
“ESH UPDATE ON COVID-19”. 2020년 4월 15일에 원본 문서에서 보존된 문서. 2020년 5월 15일에 확인함.지원되지 않는 변수 무시됨: |hrsg= (도움말); 지원되지 않는 변수 무시됨: |werk= (도움말); 지원되지 않는 변수 무시됨: |datum= (도움말)
nih.gov
ncbi.nlm.nih.gov
“Human PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
“Mouse PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
C. Tikellis, M. C. Thomas: Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. In: International journal of peptides. Vol. 2012, 2012, S. 256294, doi:10.1155/2012/256294, PMID 22536270.
W. Li, M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, M. Farzan: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. In: Nature. Vol. 426, No. 6965, November 2003, S. 450–454, doi:10.1038/nature02145, PMID 14647384
P. Towler, B. Staker, S. G. Prasad, S. Menon, J. Tang, T. Parsons, D. Ryan, M. Fisher, D. Williams, N. A. Dales, M. A. Patane, M. W. Pantoliano: ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. In: Journal of Biological Chemistry. Vol. 279, No. 17, April 2004, S. 17996–18007, doi:10.1074/jbc.M311191200, PMID 14754895.
C. A. McKinney, C. Fattah, C. M. Loughrey, G. Milligan, S. A. Nicklin: Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. In: Clinical science. Vol. 126, No. 12, June 2014, S. 815–827, doi:10.1042/CS20130436, PMID 24593683 (Review).
Y. Inoue, N. Tanaka, Y. Tanaka, S. Inoue, K. Morita, M. Zhuang, T. Hattori, K. Sugamura: Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. In: Journal of Virology. Vol. 81, No. 16, August 2007, S. 8722–8729, doi:10.1128/JVI.00253-07, PMID 17522231.
H. Wang, P. Yang, K. Liu, F. Guo, Y. Zhang, G. Zhang, C. Jiang: SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. In: Cell research. Vol. 18, No. 2, February 2008, S. 290–301, doi:10.1038/cr.2008.15, PMID 18227861.
S. Matsuyama, N. Nagata, K. Shirato, M. Kawase, M. Takeda, F. Taguchi: Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. In: Journal of Virology. Vol. 84, No. 24, December 2010, S. 12658–12664, doi:10.1128/JVI.01542-10, PMID 20926566.
S. K. Wong, W. Li, M. J. Moore, H. Choe, M. Farzan: A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. In: Journal of Biological Chemistry. Vol. 279, No. 5, January 2004, S. 3197–3201, doi:10.1074/jbc.C300520200, PMID 14670965.
L. Du, Y. He, Y. Zhou, S. Liu, B. J. Zheng, S. Jiang: The spike protein of SARS-CoV–a target for vaccine and therapeutic development. In: Nature reviews. Microbiology. Vol. 7, No. 3, March 2009, S. 226–236, doi:10.1038/nrmicro2090, PMID 19198616 (Review).
F. Li, W. Li, M. Farzan, S. C. Harrison: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. In: Science. Vol. 309, No. 5742, September 2005, S. 1864–1868, doi:10.1126/science.1116480, PMID 16166518.
F. Li: Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. In: Journal of Virology. Vol. 82, No. 14, July 2008, S. 6984–6991, doi:10.1128/JVI.00442-08, PMID 18448527.
M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T. S. Schiergens, G. Herrler, N. H. Wu, A. Nitsche, M. A. Müller, C. Drosten, S. Pöhlmann: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. In: Cell. March 2020, doi:10.1016/j.cell.2020.02.052, PMID 32142651.
T. Hirano, M. Murakami: COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. In: Immunity. [elektronische Veröffentlichung vor dem Druck] April 2020, doi:10.1016/j.immuni.2020.04.003, PMID 32325025.
Y. Y. Zheng, Y. T. Ma, J. Y. Zhang, X. Xie: COVID-19 and the cardiovascular system. In: Nature reviews. Cardiology. 5. March 2020, doi:10.1038/s41569-020-0360-5, PMID 32139904.
C. M. Ferrario, J. Jessup, M. C. Chappell, D. B. Averill, K. B. Brosnihan, E. A. Tallant, D. I. Diz, P. E. Gallagher: Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. In: Circulation. Vol. 111, No. 20, May 2005, S. 2605–2610, doi:10.1161/CIRCULATIONAHA.104.510461, PMID 15897343.
Y. Li, Z. Zeng, Y. Li, W. Huang, M. Zhou, X. Zhang, W. Jiang: Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. In: Shock. Vol. 43, No. 4, April 2015, S. 395–404, doi:10.1097/SHK.0000000000000302, PMID 25768373.
R. M. Wösten-van Asperen, R. Lutter, P. A. Specht, G. N. Moll, J. B. van Woensel, C. M. van der Loos, H. van Goor, J. Kamilic, S. Florquin, A. P. Bos: Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. In: The Journal of pathology. Vol. 225, No. 4, December 2011, S. 618–627, doi:10.1002/path.2987, PMID 22009550.
S. Keidar, A. Gamliel-Lazarovich, M. Kaplan, E. Pavlotzky, S. Hamoud, T. Hayek, R. Karry, Z. Abassi: Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. In: Circulation research. Vol. 97, No. 9, October 2005, S. 946–953, doi:10.1161/01.RES.0000187500.24964.7A, PMID 16179584.
J. C. Zhong, J. Y. Ye, H. Y. Jin, X. Yu, H. M. Yu, D. L. Zhu, P. J. Gao, D. Y. Huang, M. Shuster, H. Loibner, J. M. Guo, X. Y. Yu, B. X. Xiao, Z. H. Gong, J. M. Penninger, G. Y. Oudit: Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. In: Regulatory peptides. Vol. 166, No. 1–3, January 2011, S. 90–97, doi:10.1016/j.regpep.2010.09.005, PMID 20854846.
S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie, A. J. Turner: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. In: Journal of Biological Chemistry. Vol. 275, No. 43, October 2000, S. 33238–33243, doi:10.1074/jbc.M002615200, PMID 10924499.
W. Ding, X. Li, W. Wu, H. He, Y. Li, L. Gao, L. Gan, M. Wang, S. Ou, J. Liu: [Aliskiren inhibits angiotensin II/angiotensin 1-7(Ang II/Ang1-7) signal pathway in rats with diabetic nephropathy]. In: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. Vol. 34, No. 10, October 2018, S. 891–895, PMID 30554582 (chinesisch).
B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, D. L. Clement, A. Coca, G. de Simone, A. Dominiczak, T. Kahan, F. Mahfoud, J. Redon, L. Ruilope, A. Zanchetti, M. Kerins, S. E. Kjeldsen, R. Kreutz, S. Laurent, G. Y. Lip, R. McManus, K. Narkiewicz, F. Ruschitzka, R. E. Schmieder, E. Shlyakhto, C. Tsioufis, V. Aboyans, I. Desormais: 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. In: Journal of hypertension. Vol. 36, No. 10, 10 2018, S. 1953–2041, doi:10.1097/HJH.0000000000001940, PMID 30234752.
“ESH UPDATE ON COVID-19”. 2020년 4월 15일에 원본 문서에서 보존된 문서. 2020년 5월 15일에 확인함.지원되지 않는 변수 무시됨: |hrsg= (도움말); 지원되지 않는 변수 무시됨: |werk= (도움말); 지원되지 않는 변수 무시됨: |datum= (도움말)
“Coronavirus SARS-CoV-2”. 2020년 5월 15일에 원본 문서에서 보존된 문서. 2020-05-15] 웹 아카이브에서에 확인함.지원되지 않는 변수 무시됨: |werk= (도움말); 지원되지 않는 변수 무시됨: |abruf= (도움말); 지원되지 않는 변수 무시됨: |datum= (도움말); 지원되지 않는 변수 무시됨: |hrsg= (도움말); 지원되지 않는 변수 무시됨: |kommentar= (도움말); 다음 날짜 값 확인 필요: |access-date= (도움말)